Baskol, G. Et Al. 2022. New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients. VIRAL IMMUNOLOGY , vol.35, no.10 , 690-699.

Baskol, G., Ozel, M., Saracoglu, H., Ulger, B., Kalin Unuvar, G., Onuk, S., ... Bayram, A.(2022). New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients. VIRAL IMMUNOLOGY , vol.35, no.10, 690-699.

Baskol, Gulden Et Al. "New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients," VIRAL IMMUNOLOGY , vol.35, no.10, 690-699, 2022

Baskol, Gulden Et Al. "New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients." VIRAL IMMUNOLOGY , vol.35, no.10, pp.690-699, 2022

Baskol, G. Et Al. (2022) . "New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients." VIRAL IMMUNOLOGY , vol.35, no.10, pp.690-699.

@article{article, author={Gulden Baskol Et Al. }, title={New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients}, journal={VIRAL IMMUNOLOGY}, year=2022, pages={690-699} }